N-alkylation of highly quaternized chitosan derivatives affects the paracellular permeation enhancement in bronchial epithelia in vitro.
To access publisher's full text version of this article click on the hyperlink at the bottom of the page This study describes the structure-activity relationship for carefully characterized N-alkyl-N-quaternary chitosan derivatives as permeation enhancers for drugs that are mainly absorbed thro...
Published in: | European Journal of Pharmaceutics and Biopharmaceutics |
---|---|
Main Authors: | , , , |
Format: | Article in Journal/Newspaper |
Language: | English |
Published: |
Elsevier Science BV
2014
|
Subjects: | |
Online Access: | http://hdl.handle.net/2336/332604 https://doi.org/10.1016/j.ejpb.2013.04.002 |
id |
ftlandspitaliuni:oai:www.hirsla.lsh.is:2336/332604 |
---|---|
record_format |
openpolar |
spelling |
ftlandspitaliuni:oai:www.hirsla.lsh.is:2336/332604 2023-05-15T16:44:05+02:00 N-alkylation of highly quaternized chitosan derivatives affects the paracellular permeation enhancement in bronchial epithelia in vitro. Faculty of Pharmaceutical Sciences, School of Health Sciences, University of Iceland, Reykjavik, Iceland. 2Biomedical Center, School of Health Sciences, University of Iceland, Reykjavík, Iceland. 3Department of Pulmonary Medicine, Landspitali - The National University Hospital of Iceland, Reykjavík, Iceland. 4Faculty of Pharmaceutical Sciences, School of Health Sciences, University of Iceland, Reykjavik, Iceland Benediktsdóttir, Berglind Eva Gudjónsson, Thórarinn Baldursson, Ólafur Másson, Már 2014 http://hdl.handle.net/2336/332604 https://doi.org/10.1016/j.ejpb.2013.04.002 en eng Elsevier Science BV http://dx.doi.org/10.1016/j.ejpb.2013.04.002 Eur J Pharm Biopharm. 2014, 86 (1):55-63 1873-3441 23608635 doi:10.1016/j.ejpb.2013.04.002 http://hdl.handle.net/2336/332604 European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V Archived with thanks to European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V National Consortium - Landsaðgangur Lyfjagjöf Dose-Response Relationship Drug Chitosan/analogs & derivatives* Tight Junctions/metabolism Molecular Weight Permeability Alkylation Bronchi/cytology Bronchi/metabolism* Cell Line Cell Survival/drug effects Chitosan/chemistry Chitosan/pharmacokinetics Drug Carriers*/chemistry Drug Carriers*/pharmacokinetics Epithelial Cells/metabolism* Epithelial Cells/ultrastructure Humans Quaternary Ammonium Compounds*/chemistry Quaternary Ammonium Compounds*/pharmacokinetics Structure-Activity Relationship Tight Junctions/drug effects Article 2014 ftlandspitaliuni https://doi.org/10.1016/j.ejpb.2013.04.002 2022-05-29T08:22:00Z To access publisher's full text version of this article click on the hyperlink at the bottom of the page This study describes the structure-activity relationship for carefully characterized N-alkyl-N-quaternary chitosan derivatives as permeation enhancers for drugs that are mainly absorbed through the paracellular pathway, such as macromolecular drugs and hydrophilic drugs, in a well defined bronchial epithelial cell line. The O-methyl free derivatives used in the study were fully trimethylated (100%) N,N,N-trimethyl chitosan (TMC) and N-propyl-(QuatPropyl), N-butyl-(QuatButyl) and N-hexyl (QuatHexyl)-N,N-dimethyl chitosan, with 85-91% degree of quaternization. The fully trimethylated TMC, from 0.25mg/ml, decreased transepithelial electrical resistance (TER) in a reversible manner and enhanced the permeation of the macromolecule FITC-dextran 4kDa (FD4) 2-5 fold. TMC did not cause any alterations in the tight junction (TJ) protein claudin-4 or in F-actin architecture. QuatHexyl was the most effective polymer to produce enhanced permeation and decreased TER from 0.016mg/ml. Nevertheless, this enhanced permeation was accompanied by reduced viability and dissociation of F-actin and claudin-4 proteins. The structure-activity relationship suggests that more lipophilic derivatives show more permeation enhancement, TJ disassembly, and less viability in the order of hexyl≈butyl>propyl>methyl and demonstrates that the permeation effect is not only mediated by permanent positive charge but also by the extent of N-alkylation. These results are relevant to elucidate the structural factors contributing to the permeation enhancement of chitosan derivatives and for potential use in pulmonary applications. Eimskip Fund of University of Iceland Landspitali University Hospital Science Article in Journal/Newspaper Iceland Reykjavík Reykjavík Hirsla - Landspítali University Hospital research archive Reykjavík European Journal of Pharmaceutics and Biopharmaceutics 86 1 55 63 |
institution |
Open Polar |
collection |
Hirsla - Landspítali University Hospital research archive |
op_collection_id |
ftlandspitaliuni |
language |
English |
topic |
Lyfjagjöf Dose-Response Relationship Drug Chitosan/analogs & derivatives* Tight Junctions/metabolism Molecular Weight Permeability Alkylation Bronchi/cytology Bronchi/metabolism* Cell Line Cell Survival/drug effects Chitosan/chemistry Chitosan/pharmacokinetics Drug Carriers*/chemistry Drug Carriers*/pharmacokinetics Epithelial Cells/metabolism* Epithelial Cells/ultrastructure Humans Quaternary Ammonium Compounds*/chemistry Quaternary Ammonium Compounds*/pharmacokinetics Structure-Activity Relationship Tight Junctions/drug effects |
spellingShingle |
Lyfjagjöf Dose-Response Relationship Drug Chitosan/analogs & derivatives* Tight Junctions/metabolism Molecular Weight Permeability Alkylation Bronchi/cytology Bronchi/metabolism* Cell Line Cell Survival/drug effects Chitosan/chemistry Chitosan/pharmacokinetics Drug Carriers*/chemistry Drug Carriers*/pharmacokinetics Epithelial Cells/metabolism* Epithelial Cells/ultrastructure Humans Quaternary Ammonium Compounds*/chemistry Quaternary Ammonium Compounds*/pharmacokinetics Structure-Activity Relationship Tight Junctions/drug effects Benediktsdóttir, Berglind Eva Gudjónsson, Thórarinn Baldursson, Ólafur Másson, Már N-alkylation of highly quaternized chitosan derivatives affects the paracellular permeation enhancement in bronchial epithelia in vitro. |
topic_facet |
Lyfjagjöf Dose-Response Relationship Drug Chitosan/analogs & derivatives* Tight Junctions/metabolism Molecular Weight Permeability Alkylation Bronchi/cytology Bronchi/metabolism* Cell Line Cell Survival/drug effects Chitosan/chemistry Chitosan/pharmacokinetics Drug Carriers*/chemistry Drug Carriers*/pharmacokinetics Epithelial Cells/metabolism* Epithelial Cells/ultrastructure Humans Quaternary Ammonium Compounds*/chemistry Quaternary Ammonium Compounds*/pharmacokinetics Structure-Activity Relationship Tight Junctions/drug effects |
description |
To access publisher's full text version of this article click on the hyperlink at the bottom of the page This study describes the structure-activity relationship for carefully characterized N-alkyl-N-quaternary chitosan derivatives as permeation enhancers for drugs that are mainly absorbed through the paracellular pathway, such as macromolecular drugs and hydrophilic drugs, in a well defined bronchial epithelial cell line. The O-methyl free derivatives used in the study were fully trimethylated (100%) N,N,N-trimethyl chitosan (TMC) and N-propyl-(QuatPropyl), N-butyl-(QuatButyl) and N-hexyl (QuatHexyl)-N,N-dimethyl chitosan, with 85-91% degree of quaternization. The fully trimethylated TMC, from 0.25mg/ml, decreased transepithelial electrical resistance (TER) in a reversible manner and enhanced the permeation of the macromolecule FITC-dextran 4kDa (FD4) 2-5 fold. TMC did not cause any alterations in the tight junction (TJ) protein claudin-4 or in F-actin architecture. QuatHexyl was the most effective polymer to produce enhanced permeation and decreased TER from 0.016mg/ml. Nevertheless, this enhanced permeation was accompanied by reduced viability and dissociation of F-actin and claudin-4 proteins. The structure-activity relationship suggests that more lipophilic derivatives show more permeation enhancement, TJ disassembly, and less viability in the order of hexyl≈butyl>propyl>methyl and demonstrates that the permeation effect is not only mediated by permanent positive charge but also by the extent of N-alkylation. These results are relevant to elucidate the structural factors contributing to the permeation enhancement of chitosan derivatives and for potential use in pulmonary applications. Eimskip Fund of University of Iceland Landspitali University Hospital Science |
format |
Article in Journal/Newspaper |
author |
Benediktsdóttir, Berglind Eva Gudjónsson, Thórarinn Baldursson, Ólafur Másson, Már |
author_facet |
Benediktsdóttir, Berglind Eva Gudjónsson, Thórarinn Baldursson, Ólafur Másson, Már |
author_sort |
Benediktsdóttir, Berglind Eva |
title |
N-alkylation of highly quaternized chitosan derivatives affects the paracellular permeation enhancement in bronchial epithelia in vitro. |
title_short |
N-alkylation of highly quaternized chitosan derivatives affects the paracellular permeation enhancement in bronchial epithelia in vitro. |
title_full |
N-alkylation of highly quaternized chitosan derivatives affects the paracellular permeation enhancement in bronchial epithelia in vitro. |
title_fullStr |
N-alkylation of highly quaternized chitosan derivatives affects the paracellular permeation enhancement in bronchial epithelia in vitro. |
title_full_unstemmed |
N-alkylation of highly quaternized chitosan derivatives affects the paracellular permeation enhancement in bronchial epithelia in vitro. |
title_sort |
n-alkylation of highly quaternized chitosan derivatives affects the paracellular permeation enhancement in bronchial epithelia in vitro. |
publisher |
Elsevier Science BV |
publishDate |
2014 |
url |
http://hdl.handle.net/2336/332604 https://doi.org/10.1016/j.ejpb.2013.04.002 |
geographic |
Reykjavík |
geographic_facet |
Reykjavík |
genre |
Iceland Reykjavík Reykjavík |
genre_facet |
Iceland Reykjavík Reykjavík |
op_relation |
http://dx.doi.org/10.1016/j.ejpb.2013.04.002 Eur J Pharm Biopharm. 2014, 86 (1):55-63 1873-3441 23608635 doi:10.1016/j.ejpb.2013.04.002 http://hdl.handle.net/2336/332604 European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V |
op_rights |
Archived with thanks to European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V National Consortium - Landsaðgangur |
op_doi |
https://doi.org/10.1016/j.ejpb.2013.04.002 |
container_title |
European Journal of Pharmaceutics and Biopharmaceutics |
container_volume |
86 |
container_issue |
1 |
container_start_page |
55 |
op_container_end_page |
63 |
_version_ |
1766034402121351168 |